| 摘要 |
<p>The present invention is a method of treating hepatitis in which granulocyte/macrophage-colony stimulating factor (GM-CSF) is administered to a patient in need of such treatment with a therapeutically effective amount alone or in conjunction with α-Interferon (INF-α).</p> |
